{"id":"https://openalex.org/A5113636634","orcid":null,"observed_orcids":[],"display_name":"MD Rawlins","raw_author_names":["MD Rawlins"],"full_name":"MD Rawlins","works_count":11,"cited_by_count":395,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":8,"i10_index":6},"ids":{"openalex":"https://openalex.org/A5113636634","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I170897317","ror":"https://ror.org/00py81415","display_name":"Duke University","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]},"years":[1985]},{"institution":{"id":"https://openalex.org/I84884186","ror":"https://ror.org/01kj2bm70","display_name":"Newcastle University","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]},"years":[1995,1993,1991,1990,1989,1985]}],"last_known_institutions":[{"id":"https://openalex.org/I84884186","ror":"https://ror.org/01kj2bm70","display_name":"Newcastle University","country_code":"GB","type":"education","lineage":["https://openalex.org/I84884186"]}],"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":6,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","count":4,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10508","display_name":"Patient Safety and Medication Errors","count":2,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","count":2,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","count":2,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","value":3.1e-05,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":2.37e-05,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11917","display_name":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","value":2.18e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","value":1.63e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12108","display_name":"Management of metastatic bone disease","value":1.19e-05,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.91454017162323},{"id":"197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","score":0.5373280048370361},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.495479941368103},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.436718225479126},{"id":"144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","score":0.25775760412216187}],"counts_by_year":[{"year":1977,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1985,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":1987,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":1988,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":1989,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":1990,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":1991,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":1993,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":1994,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":1995,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":14},{"year":2013,"works_count":0,"oa_works_count":0,"cited_by_count":18},{"year":2014,"works_count":0,"oa_works_count":0,"cited_by_count":13},{"year":2015,"works_count":0,"oa_works_count":0,"cited_by_count":15},{"year":2016,"works_count":0,"oa_works_count":0,"cited_by_count":10},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":10},{"year":2018,"works_count":0,"oa_works_count":0,"cited_by_count":19},{"year":2019,"works_count":0,"oa_works_count":0,"cited_by_count":6},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":14},{"year":2021,"works_count":0,"oa_works_count":0,"cited_by_count":7},{"year":2022,"works_count":0,"oa_works_count":0,"cited_by_count":4},{"year":2023,"works_count":0,"oa_works_count":0,"cited_by_count":12},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":9},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":8},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":4}],"display_name_alternatives":["MD Rawlins"],"block_key":"m rawlins","works_api_url":"https://api.openalex.org/works?filter=author.id:A5113636634","updated_date":"2026-11-07T12:08:38","created_date":"2016-06-24T00:00:00"}